Titan Medical CEO wants to up the game in robotic surgery: Here ’s how

[Image courtesy of Titan Medical]Titan Medical – the young, upstart Canadian robotic surgery company – is making a comeback this year. Just today, the company announced the completion of initial formative human factors studies for its Sport single port robotic surgical system. The Sport system boasts the ability for a variety of surgical instruments on snake-like arms to be deployed through a single 25 mm incision for a minimally invasive surgery. Surgeons get to work at a mobile, ergonomically designed workstation with a 3D high-definition endoscopic view inside the patient. Completing the human factors study was an important milestone under the leadership of Titan’s new CEO David McNally, who took over in January. McNally previously led Domain Surgical to a successful merger with OmniGuide Surgical. He succeeded interim chief John Barker, who had replaced John Hargrove in October 2016 after the company had to put the development of the Sport platform on hold amid a lackluster funding round. (Providence, R.I.–based Ximedica and Titan revived Sport development after Titan closed on a $7 million round later in October.) Since McNally took over, there have been a number of other important developments at Toronto-based Titan: In February, the company brought in senior biomedical engineering executive Perry Genova, PhD, to be its VP of research and development; Titan in March closed on a $5 million funding round; In April, the company brought in senior executive Curtis ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News News Well Robot-Assisted Surgery Robotics Surgical Robotic Surgery surgical robotics Titan Medical Inc. Source Type: news